Carmen Cañadas

712 total citations
6 papers, 39 citations indexed

About

Carmen Cañadas is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Carmen Cañadas has authored 6 papers receiving a total of 39 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Carmen Cañadas's work include Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (2 papers) and melanin and skin pigmentation (1 paper). Carmen Cañadas is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (2 papers) and melanin and skin pigmentation (1 paper). Carmen Cañadas collaborates with scholars based in Spain, Sweden and United Kingdom. Carmen Cañadas's co-authors include Sandra Zazo, Federico Rojo, Rebeca Manso, María Tiana, Paula Gónzález-Alonso, Cristina Chamizo, Lasse D. Jensen, Asunción Fernández‐Barral, Raúl Rincón and Valentí Gómez and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Molecular Cancer Therapeutics.

In The Last Decade

Carmen Cañadas

5 papers receiving 39 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Cañadas Spain 3 28 11 10 8 6 6 39
Natalya Dyakova United States 3 49 1.8× 10 0.9× 12 1.2× 17 2.1× 6 1.0× 8 71
Anna‐Barbara Stittrich Germany 4 43 1.5× 15 1.4× 15 1.5× 10 1.3× 14 2.3× 4 65
Nora Diéguez-Martínez Spain 3 51 1.8× 11 1.0× 13 1.3× 9 1.1× 11 1.8× 3 64
Aysegül Kaymak Türkiye 5 40 1.4× 5 0.5× 8 0.8× 9 1.1× 6 1.0× 8 60
Siebe Loontiens Belgium 5 19 0.7× 12 1.1× 6 0.6× 9 1.1× 7 1.2× 10 39
Judson Belmont United States 4 45 1.6× 16 1.5× 6 0.6× 7 0.9× 8 1.3× 4 63
Duaa H. Al-Rawi United States 4 26 0.9× 11 1.0× 15 1.5× 20 2.5× 5 0.8× 6 49
Andrea Costamagna Italy 5 37 1.3× 11 1.0× 9 0.9× 19 2.4× 8 1.3× 11 60
Yi Bei China 4 61 2.2× 15 1.4× 15 1.5× 7 0.9× 3 0.5× 7 76
Hayley R. Hamilton Australia 3 14 0.5× 9 0.8× 6 0.6× 8 1.0× 6 1.0× 6 27

Countries citing papers authored by Carmen Cañadas

Since Specialization
Citations

This map shows the geographic impact of Carmen Cañadas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Cañadas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Cañadas more than expected).

Fields of papers citing papers by Carmen Cañadas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Cañadas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Cañadas. The network helps show where Carmen Cañadas may publish in the future.

Co-authorship network of co-authors of Carmen Cañadas

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Cañadas. A scholar is included among the top collaborators of Carmen Cañadas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Cañadas. Carmen Cañadas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Rincón, Raúl, Sandra Zazo, Cristina Chamizo, et al.. (2016). c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer. Molecular Cancer Therapeutics. 15(11). 2780–2790. 12 indexed citations
2.
Fernández‐Barral, Asunción, José L. Orgaz, Pablo Baquero, et al.. (2014). Regulatory and Functional Connection of Microphthalmia-Associated Transcription Factor and Anti-Metastatic Pigment Epithelium Derived Factor in Melanoma. Neoplasia. 16(6). 529–542. 23 indexed citations
3.
Izarzugaza, Yann, Manuel Dómine, Federico Rojo, et al.. (2012). Prevalence of EGFR mutations in non-small cell lung cancer (NSCLC) smoker patients.. Journal of Clinical Oncology. 30(15_suppl). e21015–e21015. 1 indexed citations
4.
Dómine, Manuel, Yann Izarzugaza, Federico Rojo, et al.. (2012). KRAS mutations as predictive biomarker in patients with EGFR wild-type stage IV nonsquamous non-small cell lung cancer (NSCLC) recruited in a phase II clinical study with carboplatin-docetaxel-bevacizumab.. Journal of Clinical Oncology. 30(15_suppl). e18069–e18069. 1 indexed citations
5.
Zazo, Sandra, Juan Madoz‐Gúrpide, Manuel Dómine, et al.. (2012). Role of c-MET pathway in the outcome prediction of cetuximab-based therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.. Journal of Clinical Oncology. 30(15_suppl). 5520–5520. 2 indexed citations
6.
Zazo, Sandra, Cristina Caramés, Gloria Serrano, et al.. (2012). Prognostic Role of Kras Mutations Detected by High-Sensitivity Taqmelt PCR Assay in Metastatic Colorectal Cancer. Annals of Oncology. 23. ix187–ix187.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026